Pharmacological management of pain in chronic pancreatitis

被引:44
作者
van Esch, A. A. J.
Wilder-Smith, O. H. G.
Jansen, J. B. M. J.
van Goor, H.
Drenth, J. P. H.
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Anaesthesiol, Pain Knowledge Ctr, NL-6500 HB Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Gen Surg, NL-6500 HB Nijmegen, Netherlands
关键词
chronic pain; chronic pancreatitis; pancreatic pain;
D O I
10.1016/j.dld.2006.02.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Pain is the major presenting symptom of chronic pancreatitis. Patients with chronic pancreatitis experience substantial impairments in health-related quality of life. Pain may be considered as the most important factor affecting the quality of life. The pathogenesis of pancreatic pain is poorly understood. The cause of pain in chronic pancreatitis is probably multifactorial. This article discusses the various hypotheses that have been suggested to underlie pain. Special attention is paid to the concept of autonomous central sensitisation and hyperalgesia as a cause of pain. Strict abstinence from alcohol is the first step of chronic pancreatic pain management. As a second step, it is important to exclude treatable complications of chronic pancreatitis, such as pseudocysts. Symptomatic treatment with analgesics is often unavoidable in patients with chronic pancreatitis. Acetaminophen, non-steroidal anti-inflammatory drugs and eventually opioids are suitable. Several trials have been performed with pancreatic enzymes, but a meta-analysis demonstrated no significant benefit in terms of pain relief. The treatment of chronic pancreatic pain requires a multidisciplinary approach that tailors the various therapeutic options to meet the need of the individual patient. (c) 2006 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:518 / 526
页数:9
相关论文
共 76 条
  • [21] Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis
    Drenth, JPH
    te Morsche, R
    Jansen, JBMJ
    [J]. GUT, 2002, 50 (05) : 687 - 692
  • [22] Analgesia from a peripherally active κ-opioid receptor agonist in patients with chronic pancreatitis
    Eisenach, JC
    Carpenter, R
    Curry, R
    [J]. PAIN, 2003, 101 (1-2) : 89 - 95
  • [23] Chronic pancreatitis: Diagnosis, classification, and new genetic developments
    Etemad, B
    Whitcomb, DC
    [J]. GASTROENTEROLOGY, 2001, 120 (03) : 682 - 707
  • [24] Intrapancreatic ductal pressure in sphincter of Oddi dysfunction
    Fazel, A
    Geenen, JE
    MoezArdalan, K
    Catalano, MF
    [J]. PANCREAS, 2005, 30 (04) : 359 - 362
  • [25] Oral ketamine for opioid-resistant acute pain
    Friedman, R
    Jallo, J
    Young, WF
    [J]. JOURNAL OF PAIN, 2001, 2 (01) : 75 - 76
  • [26] Nerve growth factor and its high-affinity receptor in chronic pancreatitis
    Friess, H
    Zhu, ZW
    di Mola, FF
    Kulli, C
    Graber, HU
    Andren-Sandberg, Å
    Zimmermann, A
    Korc, M
    Reinshagen, M
    Büchler, MW
    [J]. ANNALS OF SURGERY, 1999, 230 (05) : 615 - 624
  • [27] Survey on chronic pancreatitis in the Asia-Pacific region
    Garg, PK
    Tandon, RK
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (09) : 998 - 1004
  • [28] Descending modulation of pain
    Gebhart, GF
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2004, 27 (08) : 729 - 737
  • [29] Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity
    Gibo, J
    Ito, T
    Kawabe, K
    Hisano, T
    Inoue, M
    Fujimori, N
    Oono, T
    Arita, Y
    Nawata, H
    [J]. LABORATORY INVESTIGATION, 2005, 85 (01) : 75 - 89
  • [30] EFFECT OF CESSATION OF ALCOHOL-USE ON THE COURSE OF PANCREATIC DYSFUNCTION IN ALCOHOLIC PANCREATITIS
    GULLO, L
    BARBARA, L
    LABO, G
    [J]. GASTROENTEROLOGY, 1988, 95 (04) : 1063 - 1068